ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity

Li, Qiu; Chen, Lin; Ma, Yu-Feng; Jian, Xie-Er; Ji, Jia-Hao; You, Wen-Wei; Zhao, Pei-Liang*南方医科大学
Bioorganic Chemistry2021-11DOI: 10.1016/j.bioorg.2021.105324
7被引6阅读
引用收藏
分享

摘要

CDK4/6 have been validated as the cancer therapeutic targets. Here, we describe a series of pteridin-7(8H)-one analogues as potent CDK4/6 inhibitors. Among them, the most promising compound 7s demonstrated remarkable and broad-spectrum antiproliferative activities toward HCT116, HeLa, MDA-MB-231, and HT-29 cells with IC50 values of 0.65, 0.70, 0.39, and 2.53 mu M, respectively, which were more potent than that of the anticancer drug Palbociclib. Interestingly, 7s also manifested the greatest inhibitory activities toward both CDK4/cyclin D3 and CDK6/cyclin D3 (IC50 = 34.0 and 65.1 nM, respectively), which was comparable with Palbociclib. Additionally, molecular simulation indicated that 7s bound efficiently at the ATP binding sites of CDK4 and CDK6. Further mechanistic studies revealed that compound 7s could concentration-dependently induce cell cycle arrest and apoptosis in HeLa cells. Taken together, 7s represents a promising novel CDK4/6 inhibitor for the potential treatment of cancer.

学科与关键词

关键词
Pteridin-7(8H)-oneAntiproliferative activityCDK4/6 inhibitor
相关
加载中…
  • Synthesis and antiproliferative evaluation of novel 8-cyclopentyl-7,8-dihy-dropteridin-6(5H)-one derivatives as potential anticancer agents
    Li, Qiu; Jian, Xie-Er; Ma, Yu-Feng; Chen, Lin; Huo, Xian-Sen; Wang, Yu; He, Ren-Xin; You, Wen-Wei; Zhao, Pei-Liang*Bioorganic and Medicinal Chemistry Letters, 2021, 31: 127684.被引 3
  • Design, synthesis, and biological evaluation of N-(pyridin-3-yl) pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy
    Zeng, Wen-Bin; Ji, Tang-Yang; Zhang, Yan-Ting; Ma, Yu-Feng; Li, Rou; You, Wen-Wei; Zhao, Pei- Liang*Bioorganic Chemistry, 2024, 143: 107019.被引 1
  • Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
    Xie, Zhouling; Hou, Shuzeng; Yang, Xiaoxiao; Duan, Yajun; Han, Jihong; Wang, Qin*; Liao, Chenzhong*Journal of Medicinal Chemistry, 2022, 65(9): 6356-6389.被引 21
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2021-11
卷期
第 116 卷
页码
105324
DOI
10.1016/j.bioorg.2021.105324
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
Natural Science Foun-dation of Guangdong Province, China [2018B030311067]; Open Project of Guangdong Provincial Key Laboratory of New Drug Screening [GDKLNDS-2021OF001]

作者

  • L

    Li, Qiu (第一作者)

    new · southern med univ

  • C

    Chen, Lin

    new · southern med univ

查看全部 7 位作者收起作者
  • M

    Ma, Yu-Feng

    new · southern med univ

  • J

    Jian, Xie-Er

    new · southern med univ

  • J

    Ji, Jia-Hao

    new · southern med univ

  • Y

    You, Wen-Wei

    new · southern med univ

  • Z

    Zhao, Pei-Liang (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417